Answers are grounded in this paper and cite their sources.
Bronchiolitis is a clinical syndrome which is a major caused by respiratory syncytial virus (RSV) infection of lower respiratory tract. Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-C motif chemokine ligand 5 (CCL5) have crucial roles at the infection site. Several studies have explored cytokines in RSV; however, their discriminative performance between RSV bronchiolitis and control has not been defined completely in RSV bronchiolitis. Therefore, this study aims to investigate whether IL-6, TNF-α, and CCL5 have ability for discrimination hospital-presenting RSV bronchiolitis in children. A case-control study was conducted in 45 children with bronchiolitis and 43 healthy children. IL-6, TNF-α, and CCL5 levels were measured by a sandwich ELISA. A Significant elevation of serum IL-6, numerically higher level of serum CCL5, and significant reduction of serum TNF-α are shown in bronchiolitis children. Serum IL-6 had the highest discriminative performance (AUC= 0.954) compared with TNF-α (AUC= 0.812) and CCL5 (AUC=0.615). A significant positive correlation (r = 0.4675, P = 0.0012) was observed between the IL-6 and CCL5 levels in bronchiolitis children. Together, elevation of IL-6 could have an exploratory and preliminary performance for potential discrimination of children with hospital-presenting RSV bronchiolitis.
No takes yet. Share an insight, caveat, or question.
Rashid et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: